Cloreto de Sódio 0,9 % Labesfal, 9 mg/ml, Solução injetável, TP-102 clinical trials

A Phase 2b Clinical Study to Evaluate the Safety and Efficacy of Topical Administration of Bacteriophage Therapy TP-102 in Patients with Diabetic Foot Infection

This study looks at a new gel treatment, TP-102, for diabetic foot infections. It aims to see if TP-102 can safely and effectively help heal wounds caused by specific bacteria, compared to a dummy gel and standard care.